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Background: Tobacco products differ in their relative health harms. The need for educating consumers about such
harms is growing as different tobacco products enter the marketplace and as the FDA moves to regulate and
educate the public about different products. However, little is known about the patterns of the public’s knowledge
of relative harms.
Methods: Data were analyzed from the Health Information National Trends Survey (HINTS) 4 Cycle 2, a population-
representative survey of US adults conducted between October 2012 and January 2013 (N = 3630). Participants
reported their perceptions of the relative risks of e-cigarettes, smokeless tobacco, and different types of cigarettes
compared to “traditional” cigarettes. Relative risk perceptions for each product type, as well as the consistency and
accuracy of harm reduction beliefs, were analyzed.
Results: About 65 % of the respondents accurately reported that no cigarettes were less harmful than any others.
Slightly more than half of US adults perceived e-cigarettes to be safer than regular cigarettes, a belief in line with
current scientific evidence. By contrast, only 9 % of respondents perceived some smokeless tobacco products to be
safer, a belief strongly supported by the evidence. Only 3.5 % of respondents had patterns of relative risk
perceptions in line with current scientific evidence for all three modalities.
Conclusions: The discrepancy between current evidence and public perceptions of relative risk of various tobacco/
nicotine products was marked; for most tobacco types, a large proportion of the population held inaccurate harm
reduction beliefs. Although there was substantial awareness that no cigarettes were safer than any other cigarettes,
there could be benefits from increasing the percentage of the public that appreciates this fact, especially among
current smokers. Given the potential benefits of tobacco risk reduction strategies, public health education efforts to
increase understanding of basic harm reduction principles are needed to address these misperceptions.
Keywords: Tobacco harm reduction, Cigarettes, Smokeless tobacco, Electronic cigarettes, Public health education,
Risk perception, Health communicationIntroduction
Combusted tobacco products inhaled into the lungs are
the greatest cause of health-related harms resulting from
use of tobacco products [1, 2]. It is also acknowledged
by the United States Food and Drug Administration
(FDA) [3] and others [1, 4, 5] that there is evidence of a
continuum of risk, with cigarettes constituting the most* Correspondence: lk22@buffalo.edu
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unless otherwise stated.harmful tobacco/nicotine product and with nicotine re-
placement products, some smokeless tobacco products,
and electronic cigarettes involving relatively low levels of
risk [3, 6]. Though not welcomed by all tobacco control
authorities (e.g., [7]), there has been support for includ-
ing harm reduction strategies as one of the many trad-
itional strategies for reducing the death and disability
caused by tobacco use, particularly cigarette smoking
(e.g., [2, 8–10]). Tobacco harm reduction focuses on en-
couraging the use of less dangerous forms of tobacco/en Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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bacco/nicotine products (e.g., [4]).
The FDA through its Center for Tobacco Products in-
tends to invest in public education campaigns to “help
educate the public–especially youth–about the dangers
of regulated tobacco products” [11]. Coupled with a pro-
liferation in the marketplace of “alternative” tobacco
products (e-cigarettes, hookah, smokeless formulations)
that differ in degree of risk [6] and the influence of per-
ceptions of risk on product usage [12], it could be im-
portant for the FDA to help inform the public of the
differential risks of the use of various tobacco/nicotine
products [13].
Given the scientific consensus that cigarettes are the
most deadly form of tobacco use, the public has a right
to a clear understanding of this fact [14–16] and ef-
forts should be made to impart an understanding of
the differential health risks for various tobacco/nico-
tine products [13]. In order to accomplish this goal,
though, we need to know how the public’s understand-
ing matches current scientific knowledge about relative
harms. Given that information about risk is used to
make behavioral decisions [12], such knowledge about
public perceptions of risks will help us better under-
stand choices that individuals make about tobacco
product use. Moreover, given the ethical obligation to
communicate accurate information about harm reduc-
tion [14] and the FDA’s plans to educate the public
about tobacco, understanding where the public is at
now with respect to risk beliefs about tobacco prod-
ucts is an important step toward designing effective
programming.
To advance these goals, we examined public percep-
tions of the relative risk of different tobacco formula-
tions using data from the National Cancer Institute’s
Health Information National Trend Survey (HINTS)
4 Cycle 2 [17]. The survey included questions about
the risks, relative to “traditional” cigarettes, of differ-
ent types of cigarettes, smokeless tobacco products,
and electronic cigarettes. Tan and Bigman [18] have
reported results for e-cigarettes from this survey but
did not explore interrelationships across the multiple
tobacco harm reduction questions. We used these
questions to examine the current distribution of rela-
tive risk knowledge and, based on current epidemio-
logical understanding (reviewed below), to determine
how public perceptions match to the scientific
evidence.
Evidence for harm reduction modalities
The alternative tobacco product modalities addressed in
the HINTS survey can be organized according to the clar-
ity of what the correct, evidence-based answer should be
regarding their riskiness relative to smoking “traditional”cigarettes. The question (see “Methods” for the questions)
asking whether some cigarettes are less harmful than
others is correctly answered, “no.” The argument for
cigarettes being equal in risk is made here [19]. A key
principle for understanding this issue is to understand the
problem of compensatory smoking, in which smoking be-
havior can cause smokers to get what they desire from any
brand of conventional cigarette based on how they puff on
the cigarette (e.g., [20]).
Second, the question of whether some smokeless to-
bacco products are less harmful than cigarettes is cor-
rectly answered, “yes.” While not safe, some smokeless
tobacco formulations are significantly less dangerous to
users than cigarettes [21]. One of the most thorough
reviews was done for the European Union [22] and con-
cluded, referring to major chronic diseases that “. . . . in
relation to the risks of the above major smoking-related
diseases, and with the exception of pregnancy, [smoke-
less tobacco products] are clearly less hazardous, and
in relation to respiratory and cardiovascular disease
substantially less hazardous, than cigarette smoking.”
(p. 114–115). For cardiovascular disease, the risk re-
duction was judged as “at least 50 %,” for oral and
gastrointestinal cancer “probably also at least 50 %,”
and for respiratory disease “close to 100 %.”
Finally, for electronic cigarettes (e-cigarettes, vaping),
the question asked if they were more or less harmful than
cigarettes; the best evidence-based opinion at the present
time would be, not safe, but much lower in risk [23, 24].
Public perceptions and patterns of responses on harm
reduction
We examined descriptive statistics on the proportions of
individuals holding harm reduction beliefs about each
formulation, as well as the “match” of the public’s beliefs
and the evidence-based answers reviewed above. In
addition to assessing beliefs question by question, the
coherence or consistency of accurate beliefs across ques-
tions is important, because it could indicate a broader
understanding of the underlying etiological principles
involved.
Methods
The Health Information National Trends Survey 4 Cycle
2 dataset was analyzed. HINTS is a nationally represen-
tative survey of US adults. The Survey 4 Cycle 2 data
collection took place between October 2012 and January
2013. A mailed paper and pencil questionnaire (available
in both English and Spanish) was used to collect data.
The study design and sampling framework have both
been described in detail elsewhere [17]. Briefly, HINTS
uses a two-stage sampling design. The first stage consists
of a stratified sampling procedure based on US residen-
tial addresses to select households for inclusion. The
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individual adult in each household to complete the
study. The overall response rate was 39.9 %, resulting in
an N = 3630 for completed questionnaires.
Measures
Harm reduction beliefs
Beliefs about the relative harms of different types of cig-
arettes were assessed with the question: “In your opin-
ion, do you think that some types of cigarettes are less
harmful to a person’s health than other types?” Answer
options were Yes, No, Don’t Know. For smokeless to-
bacco, relative harms were assessed by asking “In your
opinion, do you think that some smokeless tobacco
products, such as chewing tobacco, snus and snuff are
less harmful to a person’s health than cigarettes?” with
answer options of Yes, No, Don’t know. Finally, for elec-
tronic cigarettes (e-cigarettes, vaping), the question
asked “New types of cigarettes are now available called
electronic cigarettes (also known as e-cigarettes or
personal vaporizers). These products deliver nicotine
through a vapor. Compared to smoking cigarettes, would
you say that electronic cigarettes are_______?” and in-
cluded a Likert-type response scale (1 = much less risk to
5 =much more risk).
Smoking behavior
Two questions assessed smoking behavior. First, ever
smoking behavior was assessed with the question “Have
you smoked at least 100 cigarettes in your entire life?”
Those answering yes were then asked about current
smoking behavior with the question “How often do you
now smoke cigarettes?” with response options of 1 =
everyday, 2 = some days, 3 = not at all. The combination
of these two questions was used to characterize respon-
dents as never, former, or current smokers, with in-
dividuals who reported never smoking 100 cigarettes
classified as “never” smokers, individuals who reported
having smoked at least 100 lifetime cigarettes but cur-
rently smoking not at all classified as “former” smokers,
and individuals who reported current smoking every day
or some days classified as “current” smokers.
Analysis strategy
Analyses were conducted using Stata version 14 (Stata
Corp., College Station, TX). All analyses were done using
Stata’s complex survey design commands and used the
HINTS final survey and jackknifed replication weights.
These weights account for sampling design, oversam-
pling, and non-response patterns. Descriptive statistics
were used to characterize the population distributions of
responses to each relative risk question and of the over-
all number of harm reduction beliefs. For examining the
relation of smoking status to harm reduction beliefs, weutilized Rao and Scott’s method for calculating F-test
adjusted statistics for complex survey data [25, 26].
When omnibus tests were significant, we then conducted
follow-up paired comparisons comparing different combi-
nations of smoking status using the same statistical
procedures. Finally, to test for coherence/consistency of
harm reduction beliefs across types of tobacco prod-
ucts, we coded each harm reduction belief as “accurate”
or “inaccurate”—accurate was defined as (a) no ciga-
rettes are safer, (b) smokeless is safer, and (c) e-
cigarettes are safer. We then used descriptive statistics
to characterize the proportion of the population hold-
ing each combination of beliefs.
Results
As described above, HINTS is a US nationally represen-
tative survey and all analyses were done using survey
weighted analysis techniques. Therefore, the demographic
characteristics relevant to the results reported here are
those of the US adult population.
Are some cigarettes safer? No
Table 1 presents descriptive data for perceptions of the
relative risk of different types of cigarettes. Only 13 % of
respondents believed that some types of cigarettes were
less harmful than other types. This perception differed
by smoking status, F(3.61, 176.86) = 5.68, p < .01. Current
smokers and former smokers were both more likely than
never smokers to perceive lower risks; never versus
former F(1.98, 96.89) = 3.54, p < .05; never versus current
F(1.98, 96.81) = 7.59, p < .001. Current smokers were also
more likely than former smokers to perceive lower risk;
former versus current F(2.00, 97.95) = 3.06, p < .05.
Are any smokeless products safer than cigarettes? Yes
Table 1 presents beliefs about the relative risks of
smokeless tobacco relative to cigarettes. Less than 10 %
of respondents perceived smokeless tobacco as less risky
than cigarettes. There were not differences in risk per-
ception by smoking status; F(3.27, 160.42) = 2.28, p = .07.
In other words, about 9 in 10 individuals did not know
that smokeless tobacco products are less hazardous than
cigarettes.
Are e-cigarettes safer than cigarettes? Yes
Descriptive statistics for the perceived relative risk of e-
cigarettes versus regular cigarettes are presented in
Table 2. Proportions in this table are based on the 77 %
of respondents who had heard of e-cigarettes. As can be
seen in the table, just over half of the general population
(51 %) believe e-cigarettes to be less harmful than regu-
lar cigarettes. This relative risk perception differs by
smoking status, F(6.32, 309.55) = 4.41, p < 0.001. Current
smokers were more likely to perceive e-cigarettes as less
Table 1 Harm reduction beliefs for different types of cigarettes and for smokeless tobacco products (SLT), N = 3630
Overall (percent of population (95 % CL)) By smoking status (percent of population (95 % CL))
Never smokers Former smokers Current smokers
Cigs SLT Cigs SLT Cigs SLT Cigs SLT
Yes 12.6 % 9.4 % 9.9 % 9.2 % 12.5 % 9.7 % 21.9 % 10.0 %
(10.6, 14.9) (7.7, 11.5) (8.0, 12.2) (7.1, 11.8) (8.7, 17.5) (7.7, 12.2) (15.4, 28.9) (5.8, 16.6)
No 64.9 % 73.5 % 64.1 % 70.1 % 69.0 % 77.3 % 62.0 % 76.8 %
(62.0, 67.6) (70.9, 75.9) (60.5, 67.5) (66.7, 74.6) (63.6, 73.9) (73.6, 80.1) (52.7, 70.5) (69.0, 83.1)
Don’t Know 22.6 % 17.1 % 26.0 % 19.9 % 18.6 % 13.0 % 16.6 % 13.2 %
(20.5, 24.8) (15.1, 19.4) (22.7, 29.7) (16.9, 23.2) (14.9, 22.9) (10.4, 16.1) (11.2, 24.0) (8.4, 20.2)
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never versus current F(3.22, 157.70) = 8.05, p < .001;
former versus current F(3.69, 181.00) = 4.31, p < .01. Never
smokers and former smokers did not significantly differ,
F(3.51, 171.76) = 1.04, ns.
Coherence of accurate harm reduction beliefs
Finally, with respect to patterns and coherence of harm
reduction beliefs, patterns of responses for participants
who answered all three harm reduction questions were
examined. This analysis includes approximately 70 % of
the sample. Because the e-cigarette risk question was
preceded by a screener asking participants if they had
ever heard of e-cigarettes and the risk question was only
asked of those who said yes, the sample for this analysis
drops to 70 %, given that this analysis requires valid re-
sponses on all three of the relative risk questions.
Only 3.5 % agree with the most coherent accurate view
of tobacco harm reduction that (a) no cigarettes are
safer, (b) smokeless is safer, and (c) e-cigarettes are safer.
Beyond that, 1.9 % agree only no cigarettes and smoke-
less are safer, but disagree on e-cigarettes being safer;
38 % agree only no cigarettes and e-cigarettes are safer,Table 2 Beliefs about the relative risks of e-cigarettes versus “regula
Perceived relative risk Overall (percent of population (95 % CL))
Ecigs Much less harmful 11 %
(9.2, 13)
Ecigs Less harmful 40 %
(36, 43)
Ecigs Just as harmful 46 %
(43, 49)
Ecigs More harmful 1.6 %
(1.0, 2.6)
Ecigs Much more harmful 1.2 %
(0.7, 2.3)but disagree on smokeless being safer; 44 % only think
no cigarettes are safer; 0.8 % only think smokeless is
safer; 7.7 % only think e-cigarettes are safer; and 3.1 %
who completely fail at having any accurate harm reduc-
tion belief.
Discussion
Clearly, the public does not show an expert understand-
ing of tobacco/nicotine harm reduction. These limita-
tions in the public’s understanding have the potential to
lead to both individual and public health harms. For ex-
ample, the finding here that 75 % of US adults hold the
misperception that smokeless tobacco products are just
as harmful as cigarettes is both a considerable lack of
knowledge and a serious public health problem. If a
smokeless tobacco user, for example, believes that
smokeless tobacco products carry higher oral cancer
risks than cigarettes, and therefore switches to cigarettes,
this is objectively a step toward greater harm rather than
reduced harm. One of the official warnings from the
FDA on smokeless tobacco is “WARNING: This product
is not a safe alternative to cigarettes.” This message may
contribute to the perception of harm from smokelessr” cigarettes, overall and by smoking status, N = 3630
By smoking status (percent of population (95 % CL))
Never smokers Former smokers Current smokers
8.5 % 12.2 % 16.3 %
(6.5, 11) (8.9, 16.7) (12.1, 21.4)
37.3 % 37.2 % 48.7 %
(33.5, 41.4) (32.1, 42.6) (40.8, 56.8)
50.7 % 48.2 % 33.2 %
(46.6, 54.7) (42.7, 53.7) (26.1, 41.1)
1.9 % 1.4 % 1.2 %
(0.9, 3.7) (0.7, 2.7) (0.5, 2.8)
1.6 % 0.9 % 0.6 %
(0.7, 3.5) (0.3, 3.6) (0.2, 1.6)
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smokeless tobacco products can be much safer than cig-
arettes [15]. However, our findings, in conjunction with
earlier US surveys found similar ignorance about harm
reduction from smokeless tobacco [27].
With respect to different types of cigarettes, although
the majority of US adults believe that the risks are equal,
there is room for concern for the 35 % overall who did
not know that various cigarettes are equal in risk. And it
is concerning that current smokers (21.9 %) were about
twice as likely as former smokers (12.5 %) to think some
cigarettes are safer than others. Although the FDA has
banned the “light” and “mild” descriptors on cigarettes,
there appears to have been no change in the use of filter
ventilation on lower-tar cigarettes which help make
them taste lighter and milder and contribute to the per-
ception of reduced risk [28].
These findings strongly suggest the need for accurate
and effective public health messaging around the relative
harms of different tobacco products. There is reason to
believe that such messaging could be successful. With
respect to types of cigarettes, counter-marketing of
lower-tar cigarettes has been successful in the past and
should be considered again [29, 30]. Similarly, we know
that harm reduction beliefs about smokeless tobacco
(snus) do influence the use of these products [31, 32].
With respect to the etiology of tobacco-caused health
problems and the role of different delivery systems,
some basic principles (e.g., avoiding combustion-smoke
in the lungs) would likely be easy to inform the public
about [33]. Others have noted the importance for public
education as part of the implementation of harm reduc-
tion policies [34, 35]. In addition to public health messa-
ging, accurate physician knowledge of the relative risks
of tobacco products could also be an important source
of advice for smokers [31]. This is especially important
because media reports have not helped clarify the risks
of smokeless tobacco compared to cigarettes [36].
Results from another national survey found between
40 and 46 % of adults reporting that e-cigarettes are less
harmful than cigarettes, with whites, current smokers,
young adults, and those with at least a high-school dip-
loma being the most likely to perceive reduced harm
[37]. Asking a direct question that compares the risk of
snus and cigarettes produces lower estimates of the
prevalence of reduced harm perceptions than does the
comparison of answers to separate questions on the risk
of snus and on the risk of cigarettes [38], although the
comparative question may be more consistent with the
cognitive processing of comparative risk [39].
There are some barriers to accurate and effective mes-
saging on this topic. Currently the FDA regulations
present significant barriers for manufacturers to make
cross-product risk comparisons [40]. The value of thesebarriers need to be weighed against the possible ill ef-
fects of beliefs that are currently held by the public and
that can influence behavior. Note the FDA regulations
have concerns about promoting reduced-risk products
that might increase the population level of use of this
safer product. Consumers themselves, however, can be
interested in their own levels of toxicological risk—no
matter the effects on population health. When some
products, like e-cigarettes and snus, are so much less
dangerous than cigarettes, it becomes unlikely that in-
creased levels of use could ever produce a net popula-
tion health loss in comparison to cigarettes [41].
One effective model might be the United States National
Institute on Alcohol Abuse and Alcoholism (NIAAA).
NIAAA provides information on alcohol use that can help
better understand the risks of drinking and the differences
between beverages [42]. The FDA’s plans to provide public
education on tobacco/nicotine products should include
informing the public of some rudiments of how tobacco
harm reduction occurs (e.g., avoiding inhalation of com-
busted products) and develop ways to go beyond the ser-
ious limitations of informing the public that “no product
is safe” [15].
There are, of course, limitations to the work that should
be considered. First, the survey of necessity captures be-
liefs of the public at one particular time point. Especially
in the context of newer tobacco product formulations,
public awareness, knowledge, and risk perceptions are
likely to be dynamic. Ongoing assessment of these percep-
tions and examination of changes over time would be a
valuable addition to the literature. Second, risk percep-
tions may be at least somewhat dependent on the wording
of particular questions. For example, the “types of ciga-
rettes” question is ambiguous as to what qualifies as differ-
ent types of cigarettes. There is, therefore, the possibility
that variability in how individuals interpret the question
might affect their risk perceptions.Conclusions
The discrepancy between current evidence and public per-
ceptions of relative risk of various tobacco/nicotine prod-
ucts was marked. Even for e-cigarettes, half of the public
incorrectly believed them to be just as dangerous as ciga-
rettes and an overwhelming majority of respondents incor-
rectly believed smokeless tobacco to be just as dangerous
as traditional cigarettes. Although there was substantial
awareness that no cigarettes were safer than any other cig-
arettes, there could be benefits from increasing the per-
centage of the public that appreciates this fact, especially
among current smokers. Given the potential benefits of to-
bacco risk reduction strategies, public health education ef-
forts to increase understanding of basic harm reduction
principles are needed to address these misperceptions.
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